Jamie Kates Sells 899 Shares of Cigna Group (NYSE:CI) Stock

Cigna Group (NYSE:CI) CAO Jamie Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Cigna Group Price Performance

NYSE CI traded down $1.82 during trading hours on Tuesday, reaching $292.01. The company’s stock had a trading volume of 1,081,945 shares, compared to its average volume of 1,675,567. The firm has a market capitalization of $77.25 billion, a price-to-earnings ratio of 12.38, a P/E/G ratio of 1.15 and a beta of 0.28. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The company’s 50-day moving average is $283.01 and its two-hundred day moving average is $278.16.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter in the prior year, the firm posted $6.74 EPS. Cigna Group’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is presently 26.45%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on CI shares. Royal Bank Of Canada upped their price target on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research report on Friday, May 1st. Wall Street Zen lowered Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday, June 6th. Mizuho increased their price objective on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. The Goldman Sachs Group increased their price objective on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Finally, UBS Group raised their price target on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $338.30.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Banco Bilbao Vizcaya Argentaria S.A. lifted its stake in shares of Cigna Group by 13.5% during the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after purchasing an additional 4,066 shares during the period. Compass Wealth Management LLC purchased a new position in shares of Cigna Group in the 3rd quarter worth $4,718,000. Alberta Investment Management Corp purchased a new position in shares of Cigna Group in the 3rd quarter worth $3,171,000. Distillate Capital Partners LLC raised its position in shares of Cigna Group by 19.1% in the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock worth $31,338,000 after buying an additional 17,442 shares during the period. Finally, Colrain Capital LLC raised its position in shares of Cigna Group by 106.4% in the 3rd quarter. Colrain Capital LLC now owns 22,500 shares of the health services provider’s stock worth $6,486,000 after buying an additional 11,600 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.